Search

everythinglearnresearchcommunity

for

Search:↓

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Stress-related substance P may lead to hair loss and negatively affect hair growth.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Removing MCPIP1 from myeloid cells in mice leads to hair loss and prevents skin tumors but causes pigmented spots.

EGFR is crucial for preventing hair follicle inflammation and hair loss.

HPV infection is linked to better survival in advanced anal cancer, higher radiation doses improve survival, especially in HPV-negative patients, and prostaglandin E₂ pretreatment can protect mouse hair follicles from radiation damage.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Regulatory T cells protect hair follicle stem cells by maintaining immune privilege in the skin.

Alopecia areata is a complex condition causing hair loss, linked to genetics and immune system issues, and may be related to other autoimmune diseases; treatments vary in effectiveness.

Hair loss in Rhesus macaques may be caused by a skin allergy-related condition.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Hair loss requires customized treatments based on its various causes and types.

Certain immune cells are more common on the top of the head and might help predict or treat common hair loss.

Inflammation linked to the immune response may play a role in causing various types of hair loss.

Stress can worsen skin conditions by affecting hormone levels and immune response.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

Topical Imiquimod may fight vascular tumors by affecting blood vessels or the immune system, low iron might be linked to some hair loss, removing the top skin layer helps vitamin C get in, genetic testing helps diagnose skin conditions, and too much iron could worsen skin inflammation.

Vitamin A may influence hair loss conditions like alopecia, but more research is needed to understand how.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

Phototherapy can improve various types of hair loss with minimal side effects, but more research is needed to optimize treatment.

COVID-19 can cause skin issues like rashes and hair loss, which may last even after recovery.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

A patient with a new PLEC gene mutation showed symptoms of both muscular dystrophy and myasthenia gravis, which improved with steroid treatment.

The conclusion is that women are heavily affected by autoimmune skin diseases, face significant challenges, and need better research, treatments, and healthcare policies.

Melatonin, a hormone, can help protect skin from aging by reducing stress, inflammation, and damage, and may also help treat hair loss in women.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

Psoriasis is a common, genetically influenced skin disease worsened by stress and lifestyle, but targeted treatments are promising.